超碰97人人射妻,日韩欧美在线综合网,精品国产亚洲一区二区三区,欲妇荡岳丰满少妇A片24小时

NKF makes its debut at CPHI Southeast Asia

It has opened up new channels for the company to penetrate the Southeast Asian and even the global market

2025-07-22

Learn more +
King-Friend will meet you in CPHI Malaysia！

Explore the infinite possibilities of the pharmaceutical industry!

2025-07-14

Learn more +
NKF's subsidiary Kindos's Idarubicin Hydrochloride Injection gets FDA approval for marketing

Continue to promote high-quality products and services to a new level

2025-05-26

Learn more +
NKF's subsidiary Kindos's Mitoxantrone Injection gets FDA approval for marketing

Another quick approval

2025-05-22

Learn more +
Paclitaxel For Injection (Albumin Bound) approved by US FDA

2025-05-20

Learn more +
King-Friend will meet you in CPHI Frankfurt!

Explore the infinite possibilities of the pharmaceutical industry！

2025-05-19

Learn more +
King-Friend will meet you in CPHI Shanghai!

Explore the infinite possibilities of the pharmaceutical industry！

2025-05-13

Learn more +
NKF's Liraglutide Injection gets FDA approval for marketing

Benefiting more patients around the world.

2025-04-04

Learn more +
NKF's Rocuronium Bromide Injection getting approved by NMPA

Bring new hope for health to thousands of patients.

2025-03-01

Learn more +

1
2
3

Stock price

11.330

-0.09

?2025 Nanjing King-Friend Biochemical Pharmaceutical Co.Ltd蘇ICP備13012010號

<source id="jjymb"></source>